In recent years, the wave of reform in the medical and life sciences sector has accelerated rapidly. It is imperative that we provide support with a global perspective, linking potential technologies from Japan and overseas. We have established the following systems to support our clients.
-In order to support innovative businesses in the fields of medical and nursing care, life sciences, digital health, medical devices and drug discovery, we have established partnerships with overseas regions and medical universities in order to provide non-legal support for healthcare innovation in collaboration with people with expertise in these fields. We have also established partnerships with
WE SUPPORT THE INNOVATION ACTIVITIES OF PHARMACEUTICAL AND MEDICAL DEVICE COMPANIES IN THE AREAS OF AI DIAGNOSTICS, AI-ENABLED DIAGNOSTICS AND BIOINFORMATICS TO SUPPORT THE DIGITALISATION OF THE LIFE SCIENCE SECTOR. WE ALSO PROVIDE CONSULTING SERVICES FOR THE DIGITAL TRANSFORMATION OF THE MEDICAL HEALTHCARE INDUSTRY, WHERE MEDICINE AND HEALTHCARE ARE SEAMLESSLY LINKED.
To address these issues in the field of new innovations, members of the firm have served on the ethics committee of AIST and as experts on biotechnology strategy in the Cabinet Secretariat, working on regulatory reform and public policy. We are also working with the US, Australia, Canada, the UK, Singapore, Scandinavia, Israel and other countries to bring the voice of the private sector to national strategies in the life sciences.
In the field of science and technology, the firm is able to provide assistance in the academic and technical areas of medicine and life sciences through its collaboration with Willsame Corporation. In addition, we have recently established the Life Science Incubation Council and are building a support system in collaboration with the firm's legal services.